| DIRECT COMPETITOR COMPARISON | |
| BJGP | Pvt1 | Pvt2 | Pvt3 | Industry | | Market Cap: | 239.80M | N/A | N/A | N/A | 116.56M | | Employees: | 1,273 | 2,8771 | 2501 | 2,4111 | 280 | | Qtrly Rev Growth (yoy): | 10.20% | N/A | N/A | N/A | 9.60% | | Revenue (ttm): | 142.01M | 428.80M1 | 60.70M1 | 2.41B1 | 71.35M | | Gross Margin (ttm): | 49.96% | N/A | N/A | N/A | 49.96% | | EBITDA (ttm): | 13.02M | N/A | N/A | N/A | 724.20K | | Oper Margins (ttm): | 5.03% | N/A | N/A | N/A | 7.94% | | Net Income (ttm): | -2.47M | 51.20M1 | N/A | 18.90M1 | N/A | | EPS (ttm): | -0.060 | N/A | N/A | N/A | N/A | | P/E (ttm): | N/A | N/A | N/A | N/A | 18.11 | | PEG (5 yr expected): | N/A | N/A | N/A | N/A | 0.97 | | P/S (ttm): | 1.69 | N/A | N/A | N/A | 1.29 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.65 | 0.23% | 58.35B | 12.57 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 53.73 | 0.62% | 15.54B | 17.98 | | Genzyme Corp. | GENZ | 49.84 | 0.06% | 13.23B | 28.42 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.80 | 0.76% | 39.42B | 16.94 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 52.51 | 0.04% | 9.36B | 1071.63 | | Teva Pharmaceutical Industries Limited | TEVA | 55.511 | 0.02% | 48.91B | 50.79 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.81 | -0.23% | 4.23B | 20.52 | | King Pharmaceuticals Inc. | KG | 12.22 | -0.73% | 3.03B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.63 | 0.11% | 5.69B | 114.29 | | Pfizer Inc. | PFE | 18.56 | 0.00% | 149.77B | 15.42 | | Johnson & Johnson | JNJ | 64.98 | 0.06% | 179.29B | 14.19 | | GlaxoSmithKline plc | GSK | 42.29 | -0.38% | 107.21B | 13.82 | | Sanofi-Aventis | SNY | 39.7391 | -1.42% | 103.76B | N/A | | Novartis AG | NVS | 54.39 | -0.87% | 123.53B | 16.28 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 42.45 | -1.51% | N/A | N/A | | AstraZeneca plc | AZN | 46.70 | 0.17% | 67.72B | 9.38 | | Abbott Laboratories | ABT | 54.264999 | 0.01% | 83.93B | 14.70 | | Bristol-Myers Squibb Co. | BMY | 25.56 | 0.12% | 50.63B | 13.22 |
|
| NEWS ON DIRECT COMPETITORS | | No News on Direct Competitors |
|
|